Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 175,504 | 199,012 | 216,356 | 160,890 | 102,717 |
| Cost of Goods | 15,686 | 13,904 | 12,170 | 10,098 | 5,649 |
| Gross Profit | 159,818 | 185,108 | 204,186 | 150,792 | 97,068 |
| Operating Expenses | 623,212 | 605,804 | 433,394 | 300,762 | 252,524 |
| Operating Income | -462,708 | -419,792 | -229,038 | -149,872 | -154,807 |
| Interest Expense | 13,471 | 2,285 | 7,955 | 17,326 | 18,317 |
| Other Income | 16,328 | 30,798 | 29,056 | -36,219 | 6,877 |
| Pre-tax Income | -459,851 | -391,279 | -207,937 | -203,417 | -166,247 |
| Net Income Continuous | -459,851 | -391,279 | -207,937 | -203,417 | -166,247 |
| Net Income | $-459,851 | $-391,279 | $-206,891 | $-203,417 | $-166,247 |
| EPS Basic Total Ops | -3.27 | -3.03 | -1.83 | -2.28 | -2.12 |
| EPS Basic Continuous Ops | -3.27 | -3.03 | -1.84 | -2.28 | -2.12 |
| EPS Diluted Total Ops | -3.27 | -3.03 | -1.83 | -2.28 | -2.12 |
| EPS Diluted Continuous Ops | -3.27 | -3.03 | -1.84 | -2.28 | -2.12 |
| EBITDA(a) | $-430,512 | $-392,333 | $-203,170 | $-122,583 | $-125,167 |